Clarus Iv-a, L.p. - Net Worth and Insider Trading
Clarus Iv-a, L.p. Net Worth
The estimated net worth of Clarus Iv-a, L.p. is at least $83,949 dollars as of 2024-11-13. Clarus Iv-a, L.p. is the 10% Owner of Galera Therapeutics Inc and owns about 1,678,984 shares of Galera Therapeutics Inc (GRTX) stock worth over $83,949. Details can be seen in Clarus Iv-a, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Clarus Iv-a, L.p. has not made any transactions after 2019-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Clarus Iv-a, L.p.
Clarus Iv-a, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clarus Iv-a, L.p. owns 2 companies in total, including Galera Therapeutics Inc (GRTX) , and Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Clarus Iv-a, L.p.’s form 4 insider trades.
Insider Ownership Summary of Clarus Iv-a, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2019-11-12 | 10 percent owner |
| TALS | Talaris Therapeutics Inc | 2021-05-06 | 10 percent owner |
Clarus Iv-a, L.p. Latest Holdings Summary
Clarus Iv-a, L.p. currently owns a total of 1 stock. Clarus Iv-a, L.p. owns 1,678,984 shares of Galera Therapeutics Inc (GRTX) as of November 12, 2019, with a value of $83,949.
Latest Holdings of Clarus Iv-a, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2019-11-12 | 1,678,984 | 0.05 | 83,949 |
Holding Weightings of Clarus Iv-a, L.p.
Clarus Iv-a, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Clarus Iv-a, L.p. has made a total of 0 transactions in Galera Therapeutics Inc (GRTX) over the past 5 years. The most-recent trade in Galera Therapeutics Inc is the acquisition of 250,000 shares on November 12, 2019, which cost Clarus Iv-a, L.p. around $3 Million.
Insider Trading History of Clarus Iv-a, L.p.
- 1
Clarus Iv-a, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Clarus Iv-a, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clarus Iv-a, L.p. is 6.05%. GuruFocus also compares Clarus Iv-a, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Clarus Iv-a, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clarus Iv-a, L.p.'s insider trading performs compared to the benchmark.
Performance of Clarus Iv-a, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -30.04 | | | | | |
| Relative Return to S&P 500(%) | -32.52 | | | | | |
Clarus Iv-a, L.p. Ownership Network
Ownership Network List of Clarus Iv-a, L.p.
Ownership Network Relation of Clarus Iv-a, L.p.
Clarus Iv-a, L.p. Owned Company Details
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Clarus Iv-a, L.p. is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include director & President and CEO Mel Sorensen , Chief Commercial Officer Mark Bachleda , and Chief Financial Officer Chris Degnan .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Clarus Iv-a, L.p. made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , and a net sale of 67,015 shares made by Mel Sorensen .
In summary, during the past 3 months, insiders sold 67,015 shares of Galera Therapeutics Inc (GRTX) in total and bought 0 shares, with a net sale of 67,015 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 3,712,809 shares were bought by its insiders, resulting in a net purchase of 3,645,794 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
Clarus Iv-a, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Clarus Iv-a, L.p.. You might contact Clarus Iv-a, L.p. via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
